Default HubSpot Blog

Noble Life Sciences

Recent Posts

Preclinical models of immuno-oncology therapeutics

By Noble Life Sciences | June 30th, 2021   |Categories:

Comments Off

Biodistribution studies for Cell and Gene Therapy Products

By Noble Life Sciences | June 30th, 2021   |Categories:

Figure 1. Overview of the biodistribution study of cell/gene therapy (CGT) product. The CGT product [...]

Comments Off

Influenza Vaccine and Anti-Viral Drug Development

By Noble Life Sciences | May 12th, 2021   |Categories:

Transmission electron micrograph of an influenza virus particle, or “virion” (Photo Credit: Cynthia [...]

Comments Off

Animal Models for the development of vaccines and therapeutics for influenza infections

By Noble Life Sciences | May 5th, 2021   |Categories:

Comments Off

Life after Coronavirus – Potential complications following recovery

By Noble Life Sciences | October 21st, 2020   |Categories:

Comments Off

Syngeneic mouse models for the testing of immunotherapeutics

By Noble Life Sciences | October 21st, 2020   |Categories:

Comments Off

Vaccine Development in a New Era

By Noble Life Sciences | July 6th, 2020   |Categories:

Comments Off

Challenges and Opportunities in Drug Formulation

By Noble Life Sciences | July 6th, 2020   |Categories:

Discovery of new medicines in the early phases of drug development is driven by the expansion of [...]

Comments Off

Challenges for developing COVID-19 therapeutics and vaccines

By Noble Life Sciences | April 29th, 2020   |Categories:

The current COVID-19 pandemic is caused by SARS-CoV-2, a coronavirus related to the SARS-CoV virus [...]

Comments Off

Immuno-oncology rodent models: benefits and challenges

By Noble Life Sciences | April 29th, 2020   |Categories:

Comments Off